Logical Therapeutics
Logical Therapeutics develops drugs for the treatment of diseases caused by or related with excessive inflammation.
Launch date
Employees
Market cap
-
Enterprise valuation
€61—92m (Dealroom.co estimates May 2010.)
Waltham Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | Series A | |
$30.0m | Series B | ||
| N/A | $32.5m | Late VC | |
$16.9m | Series C | ||
| Total Funding | €72.2m | ||